Trajectories of Quality of Life Among Chinese Patients Diagnosed with Nasopharynegeal Cancer
Overview
Authors
Affiliations
Objective: This secondary longitudinal analysis describes distinct quality of life trajectories during eight months of radiation therapy (RT) among patients with nasopharyngeal cancer (NPC) and examines factors differentiating these trajectories.
Methods: 253 Chinese patients with NPC scheduled for RT were assessed at pre-treatment, and 4 months and 8 months later on QoL (Chinese version of the FACT-G), optimism, pain, eating function, and patient satisfaction. Latent growth mixture modelling identified different trajectories within each of four QoL domains: Physical, Emotional, Social/family, and Functional well-being. Multinomial logistic regression compared optimism, pain, eating function, and patient satisfaction by trajectories adjusted for demographic and medical characteristics.
Results: We identified three distinct trajectories for physical and emotional QoL domains, four trajectories for social/family, and two trajectories for functional domains. Within each domain most patients (physical (77%), emotional (85%), social/family (55%) and functional (63%)) experienced relatively stable high levels of well-being over the 8-month period. Different Physical trajectory patterns were predicted by pain and optimism, whereas for Emotion-domain trajectories pain, optimism, eating enjoyment, patient satisfaction with information, and gender were predictive. Age, appetite, optimism, martial status, and household income predicted Social/family trajectories; household income, eating enjoyment, optimism, and patient satisfaction with information predicted Functional trajectories.
Conclusion: Most patients with NPC showed high stable QoL during radiotherapy. Optimism predicted good QoL. Symptom impacts varied by QoL domain. Information satisfaction was protective in emotional and functional well-being, reflecting the importance in helping patients to establish a realistic expectation of treatment impacts.
MaGee C, Gammage K Cancer Rep (Hoboken). 2025; 8(3):e70161.
PMID: 40067059 PMC: 11894819. DOI: 10.1002/cnr2.70161.
Saghatchian M, Lacas B, Charles C, Ghouadni A, Clain G, Boinon D Qual Life Res. 2021; 31(3):723-732.
PMID: 34324138 DOI: 10.1007/s11136-021-02947-6.
Xing C, Doose M, Qin B, Lin Y, Carson T, Plascak J Breast Cancer Res Treat. 2020; 184(3):901-914.
PMID: 32914357 PMC: 7657984. DOI: 10.1007/s10549-020-05901-1.
Costa D, Sundaresan P, Ager B, Turner S, Butow P Support Care Cancer. 2018; 27(2):567-571.
PMID: 30014194 DOI: 10.1007/s00520-018-4351-6.
Trajectories of quality of life following breast cancer diagnosis.
Goyal N, Levine B, Van Zee K, Naftalis E, Avis N Breast Cancer Res Treat. 2018; 169(1):163-173.
PMID: 29368310 PMC: 7439778. DOI: 10.1007/s10549-018-4677-2.